Adults’ acceptance of covid-19 vaccine for children in selected lower-and middle-income countries
5
Issued Date
2022-01-01
Resource Type
eISSN
2076393X
Scopus ID
2-s2.0-85121707303
Journal Title
Vaccines
Volume
10
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Vaccines Vol.10 No.1 (2022)
Suggested Citation
Bono S.A., Siau C.S., Chen W.S., Low W.Y., de Moura Villela E.F., Pengpid S., Hasan M.T., Sessou P., Ditekemena J.D., Amodan B.O., Hosseinipour M.C., Dolo H., Fodjo J.N.S., Colebunders R. Adults’ acceptance of covid-19 vaccine for children in selected lower-and middle-income countries. Vaccines Vol.10 No.1 (2022). doi:10.3390/vaccines10010011 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/85062
Title
Adults’ acceptance of covid-19 vaccine for children in selected lower-and middle-income countries
Author's Affiliation
Universite de Kinshasa
University of Abomey-Calavi
University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology
Swinburne University of Technology
Universiti Malaya
Universidade Federal de Goiás
University of Liverpool
UNC School of Medicine
Universiteit Antwerpen
Mahidol University
Universiti Kebangsaan Malaysia
Universiti Sains Malaysia
Jeeon Bangladesh Ltd.
Uganda Public Health Fellowship Program
Brain Research Africa Initiative (BRAIN)
São Paulo State Health Department
University of North Carolina
University of Abomey-Calavi
University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology
Swinburne University of Technology
Universiti Malaya
Universidade Federal de Goiás
University of Liverpool
UNC School of Medicine
Universiteit Antwerpen
Mahidol University
Universiti Kebangsaan Malaysia
Universiti Sains Malaysia
Jeeon Bangladesh Ltd.
Uganda Public Health Fellowship Program
Brain Research Africa Initiative (BRAIN)
São Paulo State Health Department
University of North Carolina
Other Contributor(s)
Abstract
Since emergency approval of COVID-19 vaccines for children aged between 12 and 15 years old was recently obtained in the United States and Europe, we aimed to assess the willingness to vaccinate children with a COVID-19 vaccine in lower-and middle-income countries (LMICs). Therefore, we launched an online cross-sectional survey in several LMICs. Questions relating to socio-demographic information, knowledge of COVID-19, level of fear/worry of being infected with COVID-19, and willingness to vaccinate children with the COVID-19 vaccine at 50%, 75% and 95% effectiveness levels, were asked. Of the 6571 participants (mean age = 39 ± 14 years), 64.0%, 72.6%, and 92.9% were willing to vaccinate children at 50%, 75%, and 95% effectiveness levels, respectively. Respondents who were undergraduates, who were more worried/fearful about COVID-19, had higher knowledge scores regarding COVID-19, and a higher belief that COVID-19 vaccination is important to protect others, were more willing to accept COVID-19 vaccination of children. COVID-19 vaccination of children will limit the spread of the virus, especially in schools; it may decrease the need for school closures which has a negative effect on child development. Findings from this study are useful for health promotion strategies during COVID-19 vaccination implementation among children in LMICs.